Cargando…
A randomized double-blind controlled trial of everolimus in individuals with PTEN mutations: Study design and statistical considerations
This randomized, double-blind controlled trial of everolimus in individuals with germline phosphatase and tensin homolog mutations (PTEN) was designed to evaluate the safety of everolimus compared with placebo and to evaluate the efficacy of everolimus on neurocognition and behavior compared to plac...
Autores principales: | Hardan, Antonio Y., Jo, Booil, Frazier, Thomas W., Klaas, Patricia, Busch, Robyn M., Dies, Kira A., Filip-Dhima, Rajna, Snow, Anne V., Eng, Charis, Hanna, Rabi, Zhang, Bo, Sahin, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887633/ https://www.ncbi.nlm.nih.gov/pubmed/33644493 http://dx.doi.org/10.1016/j.conctc.2021.100733 |
Ejemplares similares
-
A randomized controlled trial of everolimus for neurocognitive symptoms in PTEN hamartoma tumor syndrome
por: Srivastava, Siddharth, et al.
Publicado: (2022) -
Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN
por: Busch, Robyn M., et al.
Publicado: (2019) -
Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism
por: Frazier, Thomas W., et al.
Publicado: (2021) -
Longitudinal neurobehavioral profiles in children and young adults with PTEN hamartoma tumor syndrome and reliable methods for assessing neurobehavioral change
por: Busch, Robyn M., et al.
Publicado: (2023) -
Psychiatric Characteristics Across Individuals With PTEN Mutations
por: Steele, Morgan, et al.
Publicado: (2021)